hopefully a simple question for someone, page-2

At a presentation PS gave in the US earlier this year he stated that about $20million would be retained by DrR's to cover start up costs. He then went on in later presentations to say that ACL"s cost would be in the high single digit millions so assume 9million from that. So yes it's coming out of profits.
Do some quick calcs working on production costs of 30% of sales equates to a total of roughly $25 million in sales needs to be achieved prior to ACL receiving a cracker.

If we go further using the parameters previously discussed on this forum of 30% discount to GSK Arixtra, 30% market share, 30% production costs & staged sales ramp up it will be in the order of 7 to 8 months before ACL get that first cracker which by the way is quarterly in arrears so change that to 9 months.

So if cash burn remains slightly lower than at present we can scrape through. Of course in the meantime the SP will hibernate. What an exciting prospect.